Prokidney (PROK) Other Operating Expenses (2021)
Prokidney's (PROK) quarterly Other Operating Expenses came in at -$11.4 million in Q4 2021, down 213734.69% quarter-over-quarter from $5325.0 in Q2 2021.
Powered by 
Analysis
Prokidney (PROK) Other Operating Expenses (2021) Analysis & Trends
Prokidney (PROK) has reported Other Operating Expenses for 1 consecutive years, with -$11.4 million the latest figure, recorded in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -11.38 Mn |
| Jun 30, 2021 | 5,325.00 |
| Mar 31, 2021 | 5,182.00 |